PRESCRIBING · PART D · 2024
Total Rx claims
2,337
Beneficiaries
—
Total drug cost
$696K
Distinct drugs
33
Brand share
36.7%
Top prescribed drugs
Topiramate259 claims
Rimegepant Sulfate249 claims
Gabapentin248 claims
Sumatriptan Succinate226 claims
Erenumab-Aooe129 claims
QUALITY · MIPS · 2024
Final MIPS score
80.9
Quality
61.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.25%
Group
CROSS-REFERENCE